Menopausal Disorder Treatment Market – Growth Opportunities, Competitive Insights, and Forecast to 2029
Get 20% Off All Market Studies With Code ONLINE20 – Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends
What Is the Estimated Market Growth Potential of the Menopausal Disorder Treatment Market by 2029?
The menopausal disorder treatment market size has grown strongly in recent years. It will grow from $10.69 billion in 2024 to $11.47 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to the aging female population?, increased awareness of menopause-related health issues?, high prevalence of obesity exacerbating menopausal symptoms?, growing acceptance of hormone replacement therapy (HRT)?, and development of personalized medicine?.
The menopausal disorder treatment market size is expected to see strong growth in the next few years. It will grow to $15.2 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing expenditure on healthcare infrastructure, growing emphasis on women's health initiatives, increasing collaborations between pharmaceutical companies and research institutions, and growing urbanization leading to lifestyle changes impacting menopausal health. Major trends in the forecast period include a shift towards natural and herbal remedies?, integration of artificial intelligence in treatment planning, the emergence of wearable devices for real-time symptom monitoring, a focus on holistic wellness programs addressing menopause, and increased investment in women's health startups targeting menopause solutions.
Claim your free report sample now:
Which Key Growth Contributors Will Drive the Menopausal Disorder Treatment Market in the Next Decade?
The rising demand for hormone replacement therapies (HRT) is expected to propel the growth of the menopausal disorder treatment market going forward. Hormone replacement therapy (HRT) refers to the medical treatment that involves supplementing or replacing hormones to alleviate symptoms associated with menopause or hormone imbalances. The increase in hormone replacement therapies is driven by growing awareness and demand for effective management of menopausal symptoms and hormone imbalances. Hormone replacement therapy (HRT) treats menopausal disorder by directly replenishing estrogen and progesterone levels, helping to restore hormonal balance and alleviate disruptive symptoms such as hot flashes, night sweats, and mood swings, ultimately improving quality of life. For instance, in October 2024, the NHS Business Services Authority (NHSBSA), a UK-based organization providing a range of support services, reported that the number of HRT items prescribed rose by 22% to 13 million, accompanied by a 12% increase in identified patients from 2.3 million in 2022/23 to 2.6 million in 2023/24. Therefore, the rising demand for hormone replacement therapies is driving the growth of the menopausal disorder treatment market.
What Segments Are Covered in the Menopausal Disorder Treatment Market Report?
The menopausal disorder treatment market covered in this report is segmented –
1) By Treatment Type: Hormone Replacement Therapy, Non-Hormonal Treatment, Herbal Supplements, Lifestyle Modifications
2) By Stages: Menopause, Postmenopause, Perimenopause
3) By Application: Hot Flashes, Night Sweats, Mood Swings, Vaginal Dryness
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Hormone Replacement Therapy (HRT): Estrogen Therapy, Progesterone Therapy, Combination Therapy, Transdermal Patches, Vaginal Estrogen, Oral Tablets
2) By Non-Hormonal Treatment: Selective Estrogen Receptor Modulators (SERMs), Antidepressants, Gabapentin, Clonidine, Bisphosphonates, Calcium And Vitamin D Supplements
3) By Herbal Supplements: Black Cohosh, Red Clover, Dong Quai, Ginseng, Soy Isoflavones, Flaxseed
4) By Lifestyle Modifications: Dietary Changes, Regular Physical Exercise, Stress Management Techniques, Cognitive Behavioral Therapy (CBT), Smoking Cessation, Sleep Hygiene Practices
Which Emerging Trends Are Driving the Menopausal Disorder Treatment Market?
Major companies operating in the menopausal disorder treatment market are developing innovative nonhormonal neurokinin 3 (NK3) receptor antagonist drugs to effectively manage vasomotor symptoms without hormone therapy. Innovative nonhormonal neurokinin 3 (NK3) receptor antagonist therapies are novel therapies that block NK3 receptors to manage menopausal symptoms without using hormones. For instance, in December 2023, Astellas Pharma Inc., a Japan-based pharmaceutical company, received European Commission approval for Veozah (fezolinetant), a non-hormonal NK3 receptor antagonist for treating moderate to severe vasomotor symptoms (VMS) such as hot flashes and night sweats in menopausal women. It works by targeting neurons in the brain’s temperature control center to reduce the frequency and intensity of these symptoms.
Who Are the Most Influential Players in the Menopausal Disorder Treatment Market?
Major companies operating in the menopausal disorder treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co Inc., Novartis AG, Bayer AG, Bristol-Myers Squibb Company, Sanofi SA, AstraZeneca plc, Eli Lilly and Company, Novo Nordisk A/S, Abbott Laboratories, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Ipsen SA, Dr. Reddy’s Laboratories Ltd., Theramex, Besins Healthcare, Mithra Pharmaceuticals, Duchesnay USA, Fervent Pharmaceuticals, Joylux Inc., TherapeuticsMD Inc.
Get the full menopausal disorder treatment market report here:
Which Region Is Projected to Account for the Largest Share of the Menopausal Disorder Treatment Market?
North America was the largest region in the menopausal disorder treatment market in 2024. The regions covered in the menopausal disorder treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: The Business Research Company | LinkedIn
Comments
Post a Comment